Cell cultures as tools in biopharmacy A Braun, S Hämmerle, K Suda, B Rothen-Rutishauser, M Günthert, ... European journal of pharmaceutical sciences 11, S51-S60, 2000 | 213 | 2000 |
The biochemistry of drug metabolism-an introduction: Part 2. Redox reactions and their enzymes B Testa, SD Krämer Chemistry & Biodiversity 4 (3), 257-405, 2007 | 212 | 2007 |
Evidence-based approach to assess passive diffusion and carrier-mediated drug transport L Di, P Artursson, A Avdeef, GF Ecker, B Faller, H Fischer, JB Houston, ... Drug discovery today 17 (15-16), 905-912, 2012 | 189 | 2012 |
Absorption prediction from physicochemical parameters SD Krämer Pharmaceutical science & technology today 2 (9), 373-380, 1999 | 162 | 1999 |
Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition D Smith, P Artursson, A Avdeef, L Di, GF Ecker, B Faller, JB Houston, ... Molecular pharmaceutics 11 (6), 1727-1738, 2014 | 149 | 2014 |
Particle size and activation threshold: a new dimension of danger signaling L Rettig, SP Haen, AG Bittermann, L von Boehmer, A Curioni, SD Krämer, ... Blood 115 (22), 4533-4541, 2010 | 139 | 2010 |
The Biochemistry of Drug Metabolism–An Introduction: Part 1. Principles and overview B Testa, SD Krämer Chemistry & biodiversity 3 (10), 1053-1101, 2006 | 126 | 2006 |
The Biochemistry of Drug Metabolism–An Introduction: Part 4. Reactions of conjugation and their enzymes B Testa, SD Krämer Chemistry & biodiversity 5 (11), 2171-2336, 2008 | 122 | 2008 |
No entry for TAT (44–57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides SD Krämer, H Wunderli-Allenspach Biochimica et Biophysica Acta (BBA)-Biomembranes 1609 (2), 161-169, 2003 | 122 | 2003 |
Lipid membrane interactions of indacaterol and salmeterol: do they influence their pharmacological properties? D Lombardi, B Cuenoud, SD Krämer European journal of pharmaceutical sciences 38 (5), 533-547, 2009 | 120 | 2009 |
Towards the predictability of drug-lipid membrane interactions: the pH-dependent affinity of propranolol to phosphatidylinositol containing liposomes SD Kramer, A Braun, C Jakits-Deiser, H Wunderli-Allenspach Pharmaceutical Research 15 (5), 739, 1998 | 105 | 1998 |
Towards the predictability of drug-lipid membrane interactions: the pH-dependent affinity of propranolol to phosphatidylinositol containing liposomes SD Krämer, A Braun, C Jakits-Deiser, H Wunderli-Allenspach Pharmaceutical research 15 (5), 739-744, 1998 | 105 | 1998 |
The biochemistry of drug metabolism B Testa, SD Krämer Biochemistry, 2010 | 99* | 2010 |
Permeation of aromatic carboxylic acids across lipid bilayers: the pH-partition hypothesis revisited AV Thomae, H Wunderli-Allenspach, SD Krämer Biophysical journal 89 (3), 1802-1811, 2005 | 95 | 2005 |
[18F]Fluoro-Deoxy-Glucose Folate: A Novel PET Radiotracer with Improved in Vivo Properties for Folate Receptor Targeting CR Fischer, C Müller, J Reber, A Müller, SD Krämer, SM Ametamey, ... Bioconjugate chemistry 23 (4), 805-813, 2012 | 92 | 2012 |
The biochemistry of drug metabolism–an introduction: part 3. Reactions of hydrolysis and their enzymes B Testa, SD Kraemer Chemistry & biodiversity 4 (9), 2031-2122, 2007 | 92 | 2007 |
MDCK cell cultures as an epithelial in vitro model: cytoskeleton and tight junctions as indicators for the definition of age-related stages by confocal microscopy B Rothen-Rutishauser, SD Krämer, A Braun, M Günthert, ... Pharmaceutical research 15 (7), 964-971, 1998 | 91 | 1998 |
Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor R Slavik, U Grether, A Müller Herde, L Gobbi, J Fingerle, C Ullmer, ... Journal of medicinal chemistry 58 (10), 4266-4277, 2015 | 80 | 2015 |
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia Q Lu, JJ Rouby, PF Laterre, P Eggimann, A Dugard, ... Journal of antimicrobial chemotherapy 66 (5), 1110-1116, 2011 | 78 | 2011 |
Role of drug efflux carriers in the healthy and diseased brain DM Hermann, E Kilic, A Spudich, SD Krämer, H Wunderli‐Allenspach, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 78 | 2006 |